Publications by authors named "S Farhan Hasni"

Green chemistry focuses on reducing the environmental impacts of chemicals through sustainable practices. Traditional methods for extracting bioactive compounds from leaves, such as hydro-distillation and organic solvent extraction, have limitations, including long extraction times, high energy consumption, and potential toxic solvent residues. This study explored the use of supercritical fluid extraction (SFE), pressurized liquid extraction (PLE), and gas-expanded liquid (GXL) processes to improve efficiency and selectivity.

View Article and Find Full Text PDF

Objectives: An important pathogenic role for neutrophils in systemic lupus erythematosus (SLE) has been proposed. Neutrophils that lack brain and muscle aryl hydrocarbon receptor nuclear translocator-like 1 (), one of the clock genes, are defective in aging and proinflammatory responses. We assessed the role of in clinical and immunologic manifestations of murine lupus and in human SLE neutrophils.

View Article and Find Full Text PDF

Objective: Systemic lupus erythematosus (SLE) is a systemic autoimmune syndrome characterized by autoreactive responses to nucleic acids, dysregulation of the type I interferon (IFN-I) pathway, and accelerated atherosclerosis. The stimulator of IFN genes (STING), a cytosolic DNA sensor, has pathogenic implications in various inflammatory diseases. However, its specific role in SLE pathogenesis, particularly in tissue damage, remains unclear.

View Article and Find Full Text PDF

Clinical research advances medical knowledge and improves healthcare outcomes. However, disparities in research participation hinder progress. The Unmet Research Needs in Spondyloarthritis Conference IV highlighted critical insights and strategies to enhance equity in clinical research.

View Article and Find Full Text PDF
Article Synopsis
  • The enzyme ACOD1 is key in producing itaconate in immune cells, which may help regulate immune responses in lupus.
  • In a mouse model of lupus, ACOD1 knockout led to worsened disease symptoms, including increased inflammation and kidney damage compared to normal mice.
  • Itaconate levels were found to be lower in lupus patients than in healthy individuals, suggesting its potential use as a therapeutic target for autoimmune diseases.
View Article and Find Full Text PDF